You are here

  • Home
  • Archive
  • Volume 80, Issue 1
  • Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: ‘Online management of rheumatoid arthritis during COVID-19 pandemic’ by Zhang et al

Article Text

Article menu
Download PDFPDF
Correspondence response
Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: ‘Online management of rheumatoid arthritis during COVID-19 pandemic’ by Zhang et al
  1. Gabriel Figueroa-Parra,
  2. Carmen Magdalena Gamboa-Alonso,
  3. Dionicio Angel Galarza-Delgado
  1. Servicio de Reumatología, Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico
  1. Correspondence to Dionicio Angel Galarza-Delgado, Servicio de Reumatología, Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico; dgalarza{at}medicinauanl.mx

https://doi.org/10.1136/annrheumdis-2020-217631

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Zhang et al for the interest showed in our letter1 and appreciate their comments about the care of rheumatic patients during the COVID-19 pandemic.2 We agree that the function of all rheumatology outpatient clinics around the world has changed. It is a fact that the complexity of the care of rheumatic disease patients implies challenges, both to follow-up knew patients and control their diseases and also in the evaluation of patients with onset of new symptoms who potentially could be caused by a rheumatic disease. In patients with rheumatoid arthritis (RA), from the five clinical encounter components (vital signs, patient history, physical examination, laboratory tests and ancillary studies), patient’s history and physical examination are the most important in their diagnosis and management compared with other …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Twitter @GaboFP

    • GF-P and CMG-A contributed equally.

    • Contributors GF-P, CMG-A, and DAG-D drafted and revised the manuscript for important intellectual content.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles